| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Revenue | $368 | -10.5% |
| R&D Expense | $26K | +212.0% |
| SG&A Expense | $17K | +2.5% |
| Operating Income | -$181K | -10.7% |
| Net Income | -$181K | -10.7% |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $259 | +547.5% |
| Current Assets | $259 | +547.5% |
| Total Assets | $259 | +547.5% |
| Current Liabilities | $2.1M | +9.2% |
| Total Liabilities | $2.1M | +9.2% |
| Stockholders' Equity | -$2.1M | -9.2% |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64K | -79.1% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $64K | +79.7% |